Collagen Solutions PLC | Balance Sheet

Fiscal year is April-March. All values GBP Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,491.70
3,391.40
2,493.10
8,978.20
5,022.30
Total Accounts Receivable
125.90
569.60
474.20
806.60
1,085.80
Inventories
39.30
218.50
264.10
313.40
324.90
Other Current Assets
41.10
74.90
161.80
-
-
Total Current Assets
1,698.00
4,254.40
3,393.30
10,098.10
6,433.00
Net Property, Plant & Equipment
232.50
793.70
1,160.90
1,142.70
1,228.50
Intangible Assets
6,894.40
12,918.90
12,971.10
14,581.90
14,332.90
Total Assets
8,824.80
17,967.00
17,525.20
25,822.70
21,994.40
ST Debt & Current Portion LT Debt
-
21.80
21.00
26.40
1,009.90
Accounts Payable
45.80
214.90
352.40
306.00
296.90
Income Tax Payable
-
40.20
-
58.50
-
Other Current Liabilities
113.80
144.30
502.40
1,754.60
1,547.00
Total Current Liabilities
159.60
421.30
875.70
2,145.50
2,853.80
Long-Term Debt
-
87.60
62.80
1,879.90
1,914.10
Provision for Risks & Charges
-
-
-
-
151.80
Deferred Taxes
-
285.00
253.10
221.80
192.50
Other Liabilities
2,409.20
4,319.90
2,437.10
1,289.40
-
Total Liabilities
2,568.80
5,113.70
3,628.70
5,536.60
5,112.20
Common Equity (Total)
6,211.00
12,808.30
13,896.50
20,189.00
16,882.20
Total Shareholders' Equity
6,256.00
12,853.30
13,896.50
20,189.00
16,882.20
Total Equity
6,256.00
12,853.30
13,896.50
20,286.10
16,882.20
Liabilities & Shareholders' Equity
8,824.80
17,967.00
17,525.20
25,822.70
21,994.40
Accumulated Minority Interest
-
-
-
97.20
-
Preferred Stock (Carrying Value)
45.00
45.00
-
-
-

About Collagen Solutions

View Profile
Address
3 Robroyston Oval
Glasgow Scotland G33 1AP
United Kingdom
Employees -
Website http://collagensolutions.co.uk/
Updated 07/08/2019
Collagen Solutions Plc is a holding company, which engages in the supply, development, and manufacture of medical grade collagen components and biomaterials. The company offers products for the use in regenerative medicine, medical devices, and in-vitro diagnostics and research. It operates through the following geographical segments: Europe, Middle East, and Africa; North America; and Asia.